Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.
- DOI
- 10.1016/j.jconrel.2021.12.007
- Published
- 2022 Jan
- Container
- Journal of controlled release : official journal of the Controlled Release Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2021.12.007,
title = {Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.},
author = {Metselaar JM and Middelink LM and Wortel CH and Bos R and van Laar JM and Vonkeman HE and Westhovens R and Lammers T and Yao SL and Kothekar M and Raut A and Bijlsma JWJ},
year = {2022},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
doi = {10.1016/j.jconrel.2021.12.007},
url = {https://doi.org/10.1016/j.jconrel.2021.12.007}
}RIS
TY - JOUR TI - Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial. AU - Metselaar JM AU - Middelink LM AU - Wortel CH AU - Bos R AU - van Laar JM AU - Vonkeman HE AU - Westhovens R AU - Lammers T AU - Yao SL AU - Kothekar M AU - Raut A AU - Bijlsma JWJ PY - 2022 JO - Journal of controlled release : official journal of the Controlled Release Society DO - 10.1016/j.jconrel.2021.12.007 UR - https://doi.org/10.1016/j.jconrel.2021.12.007 ER -
APA
JM, M., LM, M., CH, W., R, B., JM, V. L., HE, V., R, W., T, L., SL, Y., M, K., A, R., & JWJ, B. (2022). Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2021.12.007
Source records
- pubmed · retrieved 2026-09-26T19:13:05.016Z